Everett E. Vokes to Oligonucleotides, Antisense
This is a "connection" page, showing publications Everett E. Vokes has written about Oligonucleotides, Antisense.
Connection Strength
0.060
-
Phase I study of G3139, a bcl-2 antisense oligonucleotide, combined with carboplatin and etoposide in patients with small-cell lung cancer. J Clin Oncol. 2004 Mar 15; 22(6):1110-7.
Score: 0.060